<p>Tempest Therapeutics Inc. announced the closing of a registered direct offering and a concurrent private placement, raising $4.25 million upfront. The company sold 1,172,414 shares of common stock at $3.625 per share in the registered direct offering. In the concurrent private placement, Tempest issued short-term unregistered warrants to purchase up to 1,172,414 shares of common stock at an exercise price of $3.50 per share. The warrants are immediately exercisable and will expire eighteen months after the effective date of the registration statement for the underlying shares. The private placement and the shares issuable upon exercise of the warrants were offered under Section 4(a)(2) of the Securities Act of 1933 and/or Regulation D, and are not registered under the Act or applicable state securities laws. Up to an additional $4.1 million in gross proceeds may be raised if the warrants are fully exercised. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tempest Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9592974-en) on November 26, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

TPST

<p>Tempest Therapeutics Inc. raised $8.35 million through a registered direct offering and private placement. The company sold shares at $3.625 each and issued warrants at $3.50 per share, potentially raising an additional $4.1 million if fully exercised. The transactions were conducted under Section 4(a)(2) of the Securities Act of 1933 and Regulation D.</p>

Tempest Therapeutics Raises $8.35 Million Through Registered Direct Offering and Private Placement